Cargando…
Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
[Image: see text] Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease where motor neurons in cortex, brain stem, and spinal cord die progressively, resulting in muscle wasting, paralysis, and death. Currently, effective therapies for ALS are lacking; however, identification of patholo...
Autores principales: | Salado, Irene G., Redondo, Miriam, Bello, Murilo L., Perez, Concepción, Liachko, Nicole F., Kraemer, Brian C., Miguel, Laetitia, Lecourtois, Magalie, Gil, Carmen, Martinez, Ana, Perez, Daniel I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969104/ https://www.ncbi.nlm.nih.gov/pubmed/24592867 http://dx.doi.org/10.1021/jm500065f |
Ejemplares similares
-
Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: García-García, Raquel, et al.
Publicado: (2021) -
Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster
por: Layalle, Sophie, et al.
Publicado: (2021) -
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020) -
Biological and Pharmacological Characterization of
Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson’s
Disease
por: Morales-Garcia, José A., et al.
Publicado: (2017) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)